Camp4 Therapeutics Corp

Penny Stocks Biotech Stocks Healthcare Stocks

$4.31

-0.25 (-5.48%)

As of Mar 29, 10:35 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 10 83%

Hold 2 17%

Sell 0 0%

Price Target

Analyst Price Target +178.7% upside

Low Target $8.14

Average Target $12.01

High Target $13.09

Current Price $4.31

Current
$4.31

Target
$12.01

$8.14 $12.01 avg $13.09

Scenario Analysis

Bear Case

$8.14

88.9%

Low target

Base Case

$12.01

+178.7%

Avg target

Bull Case

$13.09

+203.7%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$7.75

-44.4% from high

52-Week Low

$1.31

+230.3% from low

Target vs 52W High

$12.01

+55.0% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+19.8%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.0%
GILD Gilead Sciences Inc	Strong Buy	38	79%	$362.68	+158.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.1%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-13.0%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-29.7%